(Q43047523)

English

IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes

scientific article published on 16 December 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 November 2017

IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes (English)

1 reference

Europe PubMed Central

12 November 2017

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Stephanie Bibert

2

1 reference

Europe PubMed Central

12 November 2017

4

1 reference

Europe PubMed Central

12 November 2017

23

1 reference

Europe PubMed Central

12 November 2017

Pierre-Yves Bochud

object named as

Pierre-Yves Bochud

1

0 references

object named as

Markus H Heim

11

0 references

Bertrand Nalpas

object named as

Bertrand Nalpas

6

0 references

Darius Moradpour

object named as

Darius Moradpour

12

0 references

Thierry Poynard

object named as

Thierry Poynard

21

0 references

Jean-François Dufour

object named as

Jean-François Dufour

25

0 references

Zoltán Kutalik

3

object named as

Zoltán Kutalik

1 reference

Europe PubMed Central

12 November 2017

24

object named as

Stanislas Pol

1 reference

Europe PubMed Central

12 November 2017

Gladys Martinetti

18

object named as

Gladys Martinetti

1 reference

Europe PubMed Central

12 November 2017

author name string

Julien Guergnon

5

1 reference

Europe PubMed Central

12 November 2017

Nicolas Goossens

7

1 reference

Europe PubMed Central

12 November 2017

Lorenz Kuske

8

1 reference

Europe PubMed Central

12 November 2017

Beat Müllhaupt

9

1 reference

Europe PubMed Central

12 November 2017

Tillman Gerlach

10

1 reference

Europe PubMed Central

12 November 2017

Andreas Cerny

13

1 reference

Europe PubMed Central

12 November 2017

Raffaele Malinverni

14

1 reference

Europe PubMed Central

12 November 2017

Stephan Regenass

15

1 reference

Europe PubMed Central

12 November 2017

Guenter Dollenmaier

16

1 reference

Europe PubMed Central

12 November 2017

Hans Hirsch

17

1 reference

Europe PubMed Central

12 November 2017

Meri Gorgiewski

19

1 reference

Europe PubMed Central

12 November 2017

Marc Bourlière

20

1 reference

Europe PubMed Central

12 November 2017

Ioannis Theodorou

22

1 reference

Europe PubMed Central

12 November 2017

Francesco Negro

26

1 reference

Europe PubMed Central

12 November 2017

Swiss Hepatitis C Cohort Study Group

27

1 reference

Europe PubMed Central

12 November 2017

ANRS HC EP 26 Genoscan Study Group

28

1 reference

Europe PubMed Central

12 November 2017

language of work or name

0 references

publication date

16 December 2011

1 reference

Europe PubMed Central

12 November 2017

1 reference

Europe PubMed Central

12 November 2017

55

1 reference

Europe PubMed Central

12 November 2017

384-394

1 reference

Europe PubMed Central

12 November 2017

2

1 reference

Europe PubMed Central

12 November 2017

EASL Clinical Practice Guidelines: management of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

What are the comorbidities influencing the management of patients and the response to therapy in chronic hepatitis C?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

Pegylated-interferon plus ribavirin therapy in the treatment of CHC: individualization of treatment duration according to on-treatment virologic response

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

Lambda interferon inhibits hepatitis B and C virus replication

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

IL-28B/IFN-lambda 3 drives granzyme B loading and significantly increases CTL killing activity in macaques

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project).

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

Review article: predicting response in hepatitis C virus therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

Factors that predict response of patients with hepatitis B e antigen-positive chronic hepatitis B to peginterferon-alfa

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

Cohort Profile: the Swiss Hepatitis C Cohort Study (SCCS).

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

Interferon gamma receptor 2 gene variants are associated with liver fibrosis in patients with chronic hepatitis C infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

Common variation of IL28 affects gamma-GTP levels and inflammation of the liver in chronically infected hepatitis C virus patients.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

Genetic variation in the interleukin -28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

Intrahepatic and peripheral blood virus-specific cytotoxic T lymphocyte activity is associated with a response to combination IFN-alpha and ribavirin treatment among patients with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

Phenotypic and functional characterization of intrahepatic T lymphocytes during chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

Simultaneous evaluation of lymphocyte subpopulations in the liver and in peripheral blood mononuclear cells of HCV-infected patients: relationship with histological lesions

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

The presence of an intrahepatic cytotoxic T lymphocyte response is associated with low viral load in patients with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

Characterization of the mouse IFN-lambda ligand-receptor system: IFN-lambdas exhibit antitumor activity against B16 melanoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

Antitumor activity of IFN-lambda in murine tumor models

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

Interferon-lambda induces G1 phase arrest or apoptosis in oesophageal carcinoma cells and produces anti-tumour effects in combination with anti-cancer agents

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

Antitumor activity of type I and type III interferons in BNL hepatoma model

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: Role in the course of chronic viral hepatitis and the development of HCC

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

21 January 2018

In-situ immunophenotyping study of hepatic-infiltrating cytotoxic cells in chronic active hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24678

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.24678

1 reference

Europe PubMed Central

12 November 2017

1 reference

Europe PubMed Central

12 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43047523&oldid=1978753862"